Open AccessClinical and Economic Evaluation after Adopting Contingent Cell-Free DNA Screening for Fetal Trisomies in South Spain
Author(s) -
José Antonio SainzBueno,
María R. Torres,
Ignacio Peral,
Reyes Granell,
Manuel Vargas,
Pilar CarrascoGarrido,
José Antonio GarcíaMejido,
B. Santacruz,
M. M. Gil
Publication year - 2020
Publication title -
fetal diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.976
H-Index - 60
eISSN - 1421-9964
pISSN - 1015-3837
DOI - 10.1159/000508306
Subject(s) - medicine , trisomy , cell free fetal dna , prenatal screening , fetus , obstetrics , gynecology , pregnancy , prenatal diagnosis , biology , genetics
Contingent cell-free (cf) DNA screening on the basis of the first-trimester combined test (FCT) results has emerged as a cost-effective strategy for screening of trisomy 21 (T21).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom